Prostamax 20 mg

Prostamax peptide is a synthetic short peptide bioregulator developed within the Khavinson school of biogerontology research. It is classified as a prostate-tropic tetrapeptide, designed to model the action of naturally occurring tissue-derived peptides isolated from prostatic epithelium. In peptide research, Prostamax is studied as a tissue-selective compound for examining how short peptides interact with prostatic epithelial cells, modulate transcriptional activity, and influence age-related shifts in prostate-tissue biology.

At the molecular level, Prostamax is investigated for its ability to engage prostate epithelial cells and modulate gene expression patterns associated with cell differentiation, proliferation balance, and cellular-renewal signaling. Khavinson-school research has proposed that short bioregulators such as Prostamax penetrate cell and nuclear membranes and bind to specific DNA regions, thereby influencing the transcription of genes linked to tissue-specific protein synthesis. This selective signaling profile makes Prostamax a useful model for studying how short peptides regulate epithelial homeostasis under conditions of cellular aging and oxidative load.

Research interest in Prostamax peptide has centered on prostate-tissue renewal models, age-related prostatic biology, and the broader concept of peptide bioregulation in aging. Foundational work on the Khavinson family of bioregulators has linked short peptides of this type to normalization of tissue-specific gene expression, restoration of cellular function in aged research models, and improved markers of epithelial integrity (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). These findings position Prostamax as a relevant research compound in investigations of prostatic-epithelium signaling, tissue-specific peptide regulation, and age-related epithelial decline.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

The concept of peptide bioregulation originated in research conducted at the Saint Petersburg Institute of Bioregulation and Gerontology, where Professor Vladimir Khavinson and colleagues identified a family of short tissue-specific peptides isolated from animal organs. These peptides were observed to influence cellular renewal and gene expression in the tissues from which they were derived, forming the foundation of what is now known as Khavinson-school peptide research.

Within this framework, Prostamax was characterized as a prostate-tropic short peptide capable of selective interaction with prostatic epithelial cells. Laboratory observations have suggested that bioregulators of this class can engage with specific DNA sequences and modulate the transcription of tissue-restricted genes, providing a molecular basis for their tissue-selective effects.

This positioning at the intersection of peptide chemistry, epigenetic signaling, and gerontology has made Prostamax a peptide of continued interest in studies of prostate-tissue aging, epithelial homeostasis, and short-peptide gene-expression research.

1. Prostate Epithelial Cell Engagement

Prostamax is investigated for its tissue-selective interaction with prostatic epithelial cells. Laboratory models indicate that short peptides of this class may enter target cells, where they engage with intracellular structures associated with transcriptional control and cellular-renewal signaling.

2. Modulation of Tissue-Specific Gene Expression

Khavinson-school research suggests that Prostamax can influence the expression of genes involved in epithelial differentiation, proliferation balance, and tissue-specific protein synthesis. Through these effects, the peptide is studied as a model compound for tissue-restricted transcriptional regulation in prostate biology.

3. Cellular Renewal and Homeostasis Signaling

In research models of age-related prostate changes, Prostamax has been examined for its association with restored cellular-renewal markers, balanced proliferation patterns, and improved epithelial integrity. These observations support its use in laboratory studies of tissue homeostasis under conditions of biological aging.

4. Oxidative and Cellular-Stress Adaptation

Prostamax has been studied alongside other short bioregulators for potential contributions to cellular-stress adaptation. Research models report shifts in markers associated with oxidative balance and cellular resilience following exposure to Khavinson-class peptides, supporting investigation of Prostamax in stress-adaptation research.

Research Applications

Conclusion

Prostamax is a short peptide bioregulator with tissue-selective activity in prostate-epithelium research. Through engagement of prostatic epithelial cells, modulation of tissue-specific gene expression, and contributions to cellular-renewal signaling, it serves as a valuable research compound in studies of epithelial homeostasis, age-related prostate biology, and Khavinson-school peptide bioregulation.

Research Use Disclaimer

This product is intended for research and laboratory use only. It is designed exclusively for in vitro research purposes. All information provided is for educational and research reference only. This product is not intended for human or animal use. It is not a drug, food, or cosmetic and must not be marketed, labeled, or used as such. Use and handling are restricted to trained and qualified professionals.